|
1
|
Manikandan M, Deva Magendhra Rao AK,
Arunkumar G, Manickavasagam M, Rajkumar KS, Rajaraman R and
Munirajan AK: Oral squamous cell carcinoma: microRNA expression
profiling and integrative analyses for elucidation of
tumourigenesis mechanism. Mol Cancer. 15:282016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Weatherspoon DJ, Chattopadhyay A,
Boroumand S and Garcia I: Oral cavity and oropharyngeal cancer
incidence trends and disparities in the United States: 2000–2010.
Cancer Epidemiol. 39:497–504. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Tota JE, Anderson WF, Coffey C, Califano
J, Cozen W, Ferris RL, St John M, Cohen EE and Chaturvedi AK:
Rising incidence of oral tongue cancer among white men and women in
the United States, 1973–2012. Oral Oncol. 67:146–152. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Alnuaimi AD, Wiesenfeld D, O'Brien-Simpson
NM, Reynolds EC and McCullough MJ: Oral Candida colonization in
oral cancer patients and its relationship with traditional risk
factors of oral cancer: A matched case-control study. Oral Oncol.
51:139–145. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Williams HK: Molecular pathogenesis of
oral squamous carcinoma. Mol Pathol. 53:165–172. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zheng J: Energy metabolism of cancer:
Glycolysis versus oxidative phosphorylation. Oncol Lett.
4:1151–1157. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Rodríguez-Enríquez S, Marín-Hernández A,
Gallardo-Pérez JC, Carreño-Fuentes L and Moreno-Sánchez R:
Targeting of cancer energy metabolism. Mol Nutr Food Res. 53:29–48.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Olson AL and Pessin JE: Structure,
function, and regulation of the mammalian facilitative glucose
transporter gene family. Annu Rev Nutr; 16. pp. 235–256. 1996,
PubMed/NCBI
|
|
9
|
Krzeslak A, Wojcik-Krowiranda K, Forma E,
Jozwiak P, Romanowicz H, Bienkiewicz A and Brys M: Expression of
GLUT1 and GLUT3 glucose transporters in endometrial and breast
cancers. Pathol Oncol Res. 18:721–728. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Carvalho KC, Cunha IW, Rocha RM, Ayala FR,
Cajaíba MM, Begnami MD, Vilela RS, Paiva GR, Andrade RG and Soares
FA: GLUT1 expression in malignant tumors and its use as an
immunodiagnostic marker. Clinics. 66:965–972. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hayes J, Peruzzi PP and Lawler S:
MicroRNAs in cancer: Biomarkers, functions and therapy. Trends Mol
Med. 20:460–469. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chen B, Li H, Zeng X, Yang P, Liu X, Zhao
X and Liang S: Roles of microRNA on cancer cell metabolism. J
Transl Med. 10:2282012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liu M, Gao J, Huang Q, Jin Y and Wei Z:
Downregulating microRNA-144 mediates a metabolic shift in lung
cancer cells by regulating GLUT1 expression. Oncol Lett.
11:3772–3776. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yu T, Liu L, Li J, Yan M, Lin H, Liu Y,
Chu D, Tu H, Gu A and Yao M: MiRNA-10a is upregulated in NSCLC and
may promote cancer by targeting PTEN. Oncotarget. 6:30239–30250.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2-ΔΔCT method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang J, Ye C, Chen C, Xiong H, Xie B, Zhou
J, Chen Y, Zheng S and Wang L: Glucose transporter GLUT1 expression
and clinical outcome in solid tumors: A systematic review and
meta-analysis. Oncotarget. 8:16875–16886. 2017.PubMed/NCBI
|
|
17
|
Oh S, Kim H, Nam KS and Shin I: Glut1
promotes cell proliferation, migration and invasion by regulating
epidermal growth factor receptor and integrin signaling in
triple-negative breast cancer cells. BMB Rep. 50:132–137. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Shibuya K, Okada M, Suzuki S, Seino M,
Seino S, Takeda H and Kitanaka C: Targeting the facilitative
glucose transporter GLUT1 inhibits the self-renewal and
tumor-initiating capacity of cancer stem cells. Oncotarget.
6:651–661. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kraus D, Reckenbeil J, Wenghoefer M, Stark
H, Frentzen M, Allam JP, Novak N, Frede S, Götz W, Probstmeier R,
et al: Ghrelin promotes oral tumor cell proliferation by modifying
GLUT1 expression. Cell Mol Life Sci. 73:1287–1299. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chen B, Liu Y, Jin X, Lu W, Liu J, Xia Z,
Yuan Q, Zhao X, Xu N and Liang S: MicroRNA-26a regulates glucose
metabolism by direct targeting PDHX in colorectal cancer cells. BMC
Cancer. 14:4432014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lv X, Yao L, Zhang J, Han P and Li C:
Inhibition of microRNA-155 sensitizes lung cancer cells to
irradiation via suppression of HK2-modulated glucose metabolism.
Mol Med Rep. 14:1332–1338. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li P, Yang X, Cheng Y, Zhang X, Yang C,
Deng X, Li P, Tao J, Yang H, Wei J, et al: MicroRNA-218 increases
the sensitivity of bladder cancer to cisplatin by targeting Glut.
Cell Physiol Biochem. 41:921–932. 2017. View Article : Google Scholar : PubMed/NCBI
|
